The fight against fungi

  12 March 2021

A handful of scientists in academia and at small companies are working to increase the power of the antifungal stockpile. They’re designing drugs to go after new antifungal targets, creating new classes of drugs to attack existing targets, and modifying antifungal drugs to make them more selective or easier to take. The success or failure of these compounds, both as viable fungal fighters and as pharmaceutical investments, will become apparent in the next couple of years as they face approval from regulators and a tough marketplace for anti-infectives.

Further reading: C&EN
Author(s): Bethany Halford
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed